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Thrombolysis Should Be
Regarded as First-Line Therapy
for Prosthetic Valve Thrombosis
in the Absence of Contraindications
I read with great interest the retrospective, multicentric Prostethic
Valve Thrombolysis-Role of Transesophageal Echocardiography
(PRO-TEE) study in a recent issue of the Journal (1). The results
of the registry appear to confirm our previous and rather conser-
vative recommendations (2). According to these guidelines ob-
structive thrombi in patients presenting in NYHA functional class
III to IV should be treated with thrombolysis if the surgical risk is
high. However, the basis of these recommendations was an
international consensus conference held in 1994, when thrombol-
ysis of left-sided prosthetic valves was a rather debated approach.
A review of 53 studies cited in the published reports indicates the
results of thrombolysis being inferior in the period between 1974
and 1995 than between 1996 and 2003: success rate 77% versus
90%, embolism rate 13% versus 4%, death rate 7.5% versus 2.5%,
while the number of treated episodes was virtually the same (235
vs. 234). Recent reports and reviews recommend thrombolysis as
the first-line approach in the management of prosthetic valve
thrombosis irrespective of functional class or thrombus size (3–5).
In contrast, contributors to the registry conclude that throm-
bolysis should be limited to patients with thrombus size 0.8 cm2
as measured by transesophageal echocardiography (TEE). This
conclusion was based on a small number of patients coming from
14 centers over 16 years. The selection of patients into the registry
may have been biased (1). Moreover, in obstructive cases the fixed
thrombus usually cannot be measured within the valve orifice (3,4).
In contrast, mobile nonobstructive thrombi are easily measur-
able and in most cases large, at least in length, but thrombolysis of
these thrombi can be performed with negligible embolic risk (3–5).
The role of TEE is particularly essential to reveal thrombus in
nonobstructive cases (3) and serial TEE is required to monitor the
efficacy of thrombolysis (4,6). Assessment of “hemodynamic” and
“clinical results” without “thrombolytic results” does not allow the
evaluation of treatment results in nonobstructive cases. In sum-
mary, despite our previous recommendations I consider use of
thrombolysis in all patients with prosthetic valve thrombosis
irrespective of functional class and thrombus size unless contrain-
dications exist. Thus, TEE must be performed before and during
treatment.
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